Analysis of biomarkers within the initial 2 years posttransplant and 5-year kidney transplant outcomes: results from Clinical Trials in Organ Transplantation-17

BACKGROUND: An early posttransplant biomarker/surrogate marker for kidney allograft loss has the potential to guide targeted interventions. Previously published findings, including results from the Clinical Trials in Organ Transplantation (CTOT)-01 study, showed that elevated urinary chemokine CXCL9...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transplantation
Main Authors: Faddoul, Geovani, Nadkarni, Girish N, Bridges, Nancy D., Goebel, Jens, Hricik, Donald E., Formica, Richard, Menon, Madhav C, Morrison, Yvonne, Murphy, Barbara, Newell, Kenneth, Nickerson, Peter, Poggio, Emilio D., Rush, David, Heeger, Peter S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6018026/
https://ncbi.nlm.nih.gov/pubmed/29189482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0000000000002026
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados